Canary Capital Seeks SEC Nod for First Staked INJ ETF

Highlights:

• Canary Capital files for the first U.S.-staked INJ ETF with the SEC.
• The ETF offers both price exposure and staking rewards.
• Injective aims to bridge traditional and decentralized finance through this ETF.

Canary Capital has filed with the U.S. Securities and Exchange Commission to introduce the first staked INJ ETF. The move is a landmark as the U.S. moves toward regulated yield-generating crypto products. In contrast to the normal ETFs, this fund intends to bootstrap its INJ with additional incentives by staking them.

Advertisement

This staked INJ ETF will track the price of the native Injective token and share proceeds of staking with investors. This implies that investors might enjoy the gains of the increased value of the tokens and the staking revenue. The process of staking will take place via the proof-of-stake consensus mechanism provided by Injective. A section of the tokens in possession will be dedicated to staking contracts, which provide flexibility and liquidity.

1/ History is being made today!

Canary Capital just filed the first US Staked $INJ ETF with the SEC, giving institutions and everyday investors a regulated path to access the native Injective token through traditional brokerages and banking rails.

Here's why it's a big deal 🧵 pic.twitter.com/GkLtkR41N1

— Injective 🥷 (@injective) July 17, 2025

Institutional Interest in Injective Grows

The filing is in the wake of the success of other staking ETFs, such as Solana, which launched earlier this month. The increasing interest in staking-based funds has affected not only financial institutions but also regulators. The Injective blockchain, which targets decentralized finance applications, has attracted the attention of big players.

Injective has received the support of tech giants like Google Cloud and T-Mobile, which form part of its governing council. In addition, Injective Labs has provided regulatory advice to the SEC, proposing to promote innovation that will be compliant with the DeFi sector. The ETF aligns with the current trends of widening staking into regulated finance.

1/ Injective is gaining national recognition as Congress begins voting on landmark crypto bills today.

Our policy recommendations are now prominently featured on the official SEC site.

Injective is leading the way in crafting innovative crypto policy for America 🧵 pic.twitter.com/5GOtsBK2IL

— Injective 🥷 (@injective) July 15, 2025

This filing was preceded by Canary Capital creating a Delaware Trust, which is an indication of a long-term commitment. The trust will be in charge of fund operations and the selection of validators regarding staking rewards. In addition, depending on the performance and risk rating of this validator, stake earnings may amount to 11.5%.

Regulated Yield in a Staked INJ ETF

If approved, the staked INJ ETF will enable regulated access to staking rewards and asset growth for investors. In the past, the only option for staking was either technical or unregulated crypto channels. However, this ETF makes that process easy and gives institutions and retail investors an easy entry.

In Europe, 21Shares already has a staked INJ product, though Canary would be the first to present this kind of ETF in the U.S. The fund will be monitored by the SEC, and this may open up staking to the larger financial markets. Other crypto ETFs that Canary Capital has filed for include XRP and Cronos. Additional proposals in the pipeline are TRX, SUI, and Hedera, indicating an increase in altcoin trust. Over the past months, the SEC has been comparatively less strict on its position towards staking-based ETFs. This proposal was preconditioned by earlier approvals of staking ETFs. The fund is directly staked as opposed to synthetic or derivative exposure.

There are also new crypto legislations being considered by lawmakers during this Crypto Week. Such bills include the CLARITY Act and the GENIUS Act, which would make DeFi regulations more explicit. Their results can contribute to or accelerate ETF approvals such as this one. Following the filing of the ETF, INJ’s price has seen an increase of 2% to trade at $13.85. With a surge of more than 20% on the weekly chart, its market cap and trading volume have climbed to $1.37 billion and $200 million, respectively.

Advertisement